Concepedia

Yuemeng Dai

YD

14

Publications

892

Citations

12

H-Index

2001

Active since

Affiliations

University of Arkansas for Medical Sciences(Current)

Arkansas Children's Hospital

Massachusetts Institute of Technology

University of Alabama at Birmingham

Momenta Pharmaceuticals (United States)

Yuemeng Dai is an author at University of Arkansas for Medical Sciences specializing in tumor microenvironment, cell biology, and medicine.

Top concepts

Publications per year

2001–2020

14

Publications

14

Propranolol for infantile hemangiomas: Early experience at a tertiary vascular anomalies center

Lisa M. Buckmiller, Patrick D. Munson, Umesh Dyamenahalli et al. · The Laryngoscope · 2010 · 202 citations

HSulf-1 and HSulf-2 Are Potent Inhibitors of Myeloma Tumor Growth in Vivo

Yuemeng Dai, Yang Yang, Veronica MacLeod et al. · Journal of Biological Chemistry · 2005 · 138 citations · Full text

, , +16

The syndecan-1 heparan sulfate proteoglycan is a viable target for myeloma therapy

Yang Yang, Veronica MacLeod, Yuemeng Dai et al. · Blood · 2007 · 127 citations · Full text

Syndecan-1 Is Required for Robust Growth, Vascularization, and Metastasis of Myeloma Tumors in Vivo

Yekaterina B. Khotskaya, Yuemeng Dai, Joseph P. Ritchie et al. · Journal of Biological Chemistry · 2009 · 97 citations · Full text

Tumor heterogeneity in small hepatocellular carcinoma: Analysis of tumor cell proliferation, expression and mutation of p53 AND ?-catenin

Feng-Qi An, Masanori Matsuda, Hideki Fujii et al. · International Journal of Cancer · 2001 · 79 citations · Full text

Rows per page

1–5 of 14